Pluri (PLUR) Change in Receivables (2010 - 2025)
Pluri (PLUR) reported Change in Receivables of -$125000.0 for Q4 2025, down 256.25% year-over-year from $80000.0 in Q4 2024, and down 315.52% quarter-over-quarter from $58000.0 in Q3 2025.
Pluri (PLUR) Change in Receivables (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 13 years of Change in Receivables data on file, last reported at -$125000.0 in Q4 2025.
- Change in Receivables for Q4 2025 came in at -$125000.0, down 256.25% year-over-year; the trailing twelve-month figure through Dec 2025 was $29000.0 (down 72.64% YoY), and the FY2025 annual result was $202000.0, up 365.79% from the prior year.
- Change in Receivables slipped to -$125000.0 in Q4 2025 per PLUR's latest filing, from $58000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $80000.0 in Q4 2024 and troughed at -$125000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -4.08 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -125,000.00 |
| Dec 31, 2025 | -125,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Sep 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Dec 31, 2024 | 80,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2024 | 26,000.00 |
| Sep 30, 2020 | -142,000.00 |
| Sep 30, 2020 | -142,000.00 |
| Jun 30, 2020 | 87,000.00 |
| Jun 30, 2020 | 87,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Mar 31, 2020 | 1,000.00 |
| Dec 31, 2019 | -17,000.00 |
| Dec 31, 2019 | -17,000.00 |